Company intelligence / Profile preview

FutureTech Strategies

Skaneateles, New York, United States

Ownership: Private
Development stage: Other

Overview

FutureTech Strategies is a private healthcare and life sciences consulting firm led by physician executive Art Combs. Available public references indicate the company focuses on life sciences and entrepreneurship consulting, with particular emphasis on non-invasive technologies, digital health, and continuously measured digital biomarkers rather than on developing a proprietary therapeutic pipeline. The firm appears to provide strategic advisory support to startups and healthcare innovators, drawing on leadership experience across multiple life sciences startups and medical products businesses. Based on the available evidence, it is better characterized as a consulting/advisory business than as a biotech or pharma drug developer.

Industry: Consulting

Beyond the preview

Go deeper on FutureTech Strategies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FutureTech Strategies.

Explore the full profile